Psychological consequences of COVID-19 pandemic in Italian MS patients: signs of resilience?
Adult
Anxiety
/ epidemiology
COVID-19
/ psychology
Depression
/ epidemiology
Female
Humans
Italy
Male
Middle Aged
Multiple Sclerosis
/ psychology
Pandemics
Personal Satisfaction
Psychiatric Status Rating Scales
Quality of Life
Quarantine
/ psychology
Resilience, Psychological
Sexuality
Social Behavior
Anxiety
COVID-19
Depression
Lockdown
Multiple sclerosis
Sexual satisfaction
Journal
Journal of neurology
ISSN: 1432-1459
Titre abrégé: J Neurol
Pays: Germany
ID NLM: 0423161
Informations de publication
Date de publication:
Mar 2021
Mar 2021
Historique:
received:
27
05
2020
accepted:
20
07
2020
revised:
17
07
2020
pubmed:
30
7
2020
medline:
5
3
2021
entrez:
30
7
2020
Statut:
ppublish
Résumé
Anxiety, depression and reduction of quality of life (QoL) are common in people with multiple sclerosis (pwMS). Fear of getting sick from COVID-19, government's lockdown and the imposed social distancing might have had an impact on psychological distress and QoL. The aim of our study was to investigate anxiety, depression and QoL changes in pwMS during SARS-CoV-2 outbreak and lockdown in Italy. 67 pwMS with a previous (less than 6 months) neuropsychological evaluation before SARS-CoV-2 outbreak (T0) were re-evaluated at the time of the outbreak and lockdown in Italy (T1). They underwent a clinical and neurological evaluation and completed the State-Trait Anxiety Inventory (STAI-Y1), the Beck Depression Inventory second edition (BDI-II), and Multiple Sclerosis Quality of Life-54 (MsQoL-54) at T0 and T1. Benjamini-Hochberg procedure was applied to control the false discovery rate. BDI-II and STAI-Y1 scores did not change between T0 and T1. At T1, MsQoL-54 scores were higher on the satisfaction with sexual life and the social function subscales, and lower on the limitation due to emotional problems subscale. This is the first study that evaluated mood and QoL levels before and during the lockdown due to COVID-19 pandemic in pwMS. No worsening of anxiety and depression levels was found. Contrariwise some improvements were noted on QoL, the most reliable regarding the sexual satisfaction and the social function.
Sections du résumé
BACKGROUND
BACKGROUND
Anxiety, depression and reduction of quality of life (QoL) are common in people with multiple sclerosis (pwMS). Fear of getting sick from COVID-19, government's lockdown and the imposed social distancing might have had an impact on psychological distress and QoL.
OBJECTIVES
OBJECTIVE
The aim of our study was to investigate anxiety, depression and QoL changes in pwMS during SARS-CoV-2 outbreak and lockdown in Italy.
METHODS
METHODS
67 pwMS with a previous (less than 6 months) neuropsychological evaluation before SARS-CoV-2 outbreak (T0) were re-evaluated at the time of the outbreak and lockdown in Italy (T1). They underwent a clinical and neurological evaluation and completed the State-Trait Anxiety Inventory (STAI-Y1), the Beck Depression Inventory second edition (BDI-II), and Multiple Sclerosis Quality of Life-54 (MsQoL-54) at T0 and T1. Benjamini-Hochberg procedure was applied to control the false discovery rate.
RESULTS
RESULTS
BDI-II and STAI-Y1 scores did not change between T0 and T1. At T1, MsQoL-54 scores were higher on the satisfaction with sexual life and the social function subscales, and lower on the limitation due to emotional problems subscale.
CONCLUSIONS
CONCLUSIONS
This is the first study that evaluated mood and QoL levels before and during the lockdown due to COVID-19 pandemic in pwMS. No worsening of anxiety and depression levels was found. Contrariwise some improvements were noted on QoL, the most reliable regarding the sexual satisfaction and the social function.
Identifiants
pubmed: 32725312
doi: 10.1007/s00415-020-10099-9
pii: 10.1007/s00415-020-10099-9
pmc: PMC7385478
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
743-750Références
Wu C, Chen X, Cai Y et al (2020) Risk factors associated with acute respiratory distress syndrome and death in patients with coronavirus disease 2019 Pneumonia in Wuhan, China. JAMA Intern Med. https://doi.org/10.1001/jamainternmed.2020.0994
doi: 10.1001/jamainternmed.2020.0994
pubmed: 33284315
pmcid: 7070509
(2020) MS International Federation Global COVID-19 advice for people with MS. Retrieved from: https://www.msif.org/wp-content/uploads/2020/03/MSIF-Global-advice-on-COVID-19-for-people-with-MS.docx.pdf . Accessed 27 May 2020
Italian Society of Neurology (SIN) and Italian MS Association (AISM) (2020) Indicazioni sulla gestione del paziente con SM nel corso di epidemia da COVID-19. Retrieved from: https://www.aism.it/sites/default/files/ComunicazioneGdSSINSM-Coronavirus.pdf . Accessed 27 May 2020
Boeschoten RE, Braamse AMJ, Beekman ATF et al (2017) Prevalence of depression and anxiety in Multiple Sclerosis: a systematic review and meta-analysis. J Neurol Sci 372:331–341
doi: 10.1016/j.jns.2016.11.067
Dahl OP, Stordal E, Lydersen S, Midgard R (2009) Anxiety and depression in multiple sclerosis. A comparative population-based study in Nord-Trøndelag County. Norway Mult Scler 15:1495–1501. https://doi.org/10.1177/1352458509351542
doi: 10.1177/1352458509351542
pubmed: 19965515
Feinstein A, O’Connor P, Gray T, Feinstein K (1999) The effects of anxiety on psychiatric morbidity in patients with multiple sclerosis. Mult Scler 5:323–326. https://doi.org/10.1177/135245859900500504
doi: 10.1177/135245859900500504
pubmed: 10516775
Korostil M, Feinstein A (2007) Anxiety disorders and their clinical correlates in multiple sclerosis patients. Mult Scler 13:67–72. https://doi.org/10.1177/1352458506071161
doi: 10.1177/1352458506071161
pubmed: 17294613
Beiske AG, Svensson E, Sandanger I et al (2008) Depression and anxiety amongst multiple sclerosis patients. Eur J Neurol 15:239–245. https://doi.org/10.1111/j.1468-1331.2007.02041.x
doi: 10.1111/j.1468-1331.2007.02041.x
pubmed: 18215155
Chwastiak L, Ehde DM, Gibbons LE et al (2002) Depressive symptoms and severity of illness in multiple sclerosis: epidemiologic study of a large community sample. Am J Psychiatry 159:1862–1868. https://doi.org/10.1176/appi.ajp.159.11.1862
doi: 10.1176/appi.ajp.159.11.1862
pubmed: 12411220
Schiffer RB, Arnett P, Ben-Zacharia A et al (2005) The Goldman Consensus statement on depression in multiple sclerosis. Mult Scler J 11:328–337. https://doi.org/10.1191/1352458505ms1162oa
doi: 10.1191/1352458505ms1162oa
Siegert RJ, Abernethy DA (2005) Depression in multiple sclerosis: a review. J Neurol Neurosurg Psychiatry 76:469–475
doi: 10.1136/jnnp.2004.054635
Sadovnick AD, Remick RA, Allen J et al (1996) Depression and multiple sclerosis. Neurology 46:628–632. https://doi.org/10.1212/WNL.46.3.628
doi: 10.1212/WNL.46.3.628
pubmed: 8618657
Giordano A, Granella F, Lugaresi A et al (2011) Anxiety and depression in multiple sclerosis patients around diagnosis. J Neurol Sci 307:86–91. https://doi.org/10.1016/j.jns.2011.05.008
doi: 10.1016/j.jns.2011.05.008
pubmed: 21621796
Morrow SA, Drake A, Zivadinov R et al (2010) Predicting loss of employment over three years in multiple sclerosis: clinically meaningful cognitive decline. Clin Neuropsychol 24:1131–1145. https://doi.org/10.1080/13854046.2010.511272
doi: 10.1080/13854046.2010.511272
pubmed: 20830649
Simmons RD (2010) Life issues in multiple sclerosis. Nat Rev Neurol 6:603–610
doi: 10.1038/nrneurol.2010.143
Smith MM, Arnett PA (2005) Factors related to employment status changes in individuals with multiple sclerosis. Mult Scler 11:602–609. https://doi.org/10.1191/1352458505ms1204oa
doi: 10.1191/1352458505ms1204oa
pubmed: 16193900
Thompson AJ, Banwell BL, Barkhof F et al (2018) Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Lancet Neurol 17:162–173
doi: 10.1016/S1474-4422(17)30470-2
Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444–1452. https://doi.org/10.1212/wnl.33.11.1444
doi: 10.1212/wnl.33.11.1444
pubmed: 6685237
Amato MP, Portaccio E, Goretti B et al (2006) The Rao’s Brief Repeatable Battery and Stroop Test: normative values with age, education and gender corrections in an Italian population. Mult Scler 12:787–793. https://doi.org/10.1177/1352458506070933
doi: 10.1177/1352458506070933
pubmed: 17263008
Van Schependom J, D’hooghe MB, Cleynhens K et al (2014) The Symbol Digit Modalities Test as sentinel test for cognitive impairment in multiple sclerosis. Eur J Neurol 21:1219–1225. https://doi.org/10.1111/ene.12463 (e71–e72)
doi: 10.1111/ene.12463
pubmed: 24850580
Santangelo G, Sacco R, Siciliano M et al (2016) Anxiety in Multiple Sclerosis: psychometric properties of the State-Trait Anxiety Inventory. Acta Neurol Scand 134:458–466. https://doi.org/10.1111/ane.12564
doi: 10.1111/ane.12564
pubmed: 27219913
Sacco R, Santangelo G, Stamenova S et al (2016) Psychometric properties and validity of Beck Depression Inventory II in multiple sclerosis. Eur J Neurol 23:744–750. https://doi.org/10.1111/ene.12932
doi: 10.1111/ene.12932
pubmed: 26782789
Solari A, Filippini G, Mendozzi L et al (1999) Validation of Italian multiple sclerosis quality of life 54 questionnaire. J Neurol Neurosurg Psychiatry 67:158–162. https://doi.org/10.1136/jnnp.67.2.158
doi: 10.1136/jnnp.67.2.158
pubmed: 10406981
pmcid: 1736469
Hochberg Y, Benjamini Y (1990) More powerful procedures for multiple significance testing. Stat Med 9:811–818. https://doi.org/10.1002/sim.4780090710
doi: 10.1002/sim.4780090710
pubmed: 2218183
Naser Moghadasi A (2020) One aspect of coronavirus disease (COVID-19) outbreak in Iran high anxiety among MS patients. Mult Scler Relat Disord 41:102138. https://doi.org/10.1016/j.msard.2020.102138
doi: 10.1016/j.msard.2020.102138
pubmed: 32335508
pmcid: 7169888
Mazza C, Ricci E, Biondi S et al (2020) A Nationwide Survey of Psychological Distress among Italian People during the COVID-19 pandemic: immediate psychological responses and associated factors. Int J Environ Res Public Health. https://doi.org/10.3390/ijerph17093165
doi: 10.3390/ijerph17093165
pubmed: 33396363
pmcid: 7795888
Perrin PC, McCabe OL, Everly GS, Links JM (2009) Preparing for an influenza pandemic: mental health considerations. Prehosp Disaster Med 24:223–230
doi: 10.1017/S1049023X00006853
Italian Health Ministry (2020) Retrieved: https://www.salute.gov.it/imgs/C_17_notizie_4767_0_file.pdf
Nazari F, Shaygannejad V, Mohammadi Sichani M et al (2020) Sexual dysfunction in women with multiple sclerosis: prevalence and impact on quality of life. BMC Urol. https://doi.org/10.1186/s12894-020-0581-2
doi: 10.1186/s12894-020-0581-2
pubmed: 32493262
pmcid: 7268392
Tepavcevic DK, Kostic J, Basuroski ID et al (2008) The impact of sexual dysfunction on the quality of life measured by MSQoL-54 in patients with multiple sclerosis. Mult Scler 14:1131–1136. https://doi.org/10.1177/1352458508093619
doi: 10.1177/1352458508093619
pubmed: 18632783
Blackmore DE, Hart SL, Albiani JJ, Mohr DC (2011) Improvements in partner support predict sexual satisfaction among individuals with multiple sclerosis. Rehabil Psychol 56:117–122. https://doi.org/10.1037/a0023362
doi: 10.1037/a0023362
pubmed: 21574730
pmcid: 3645911
Henry A, Tourbah A, Camus G et al (2019) Anxiety and depression in patients with multiple sclerosis: the mediating effects of perceived social support. Mult Scler Relat Disord 27:46–51. https://doi.org/10.1016/j.msard.2018.09.039
doi: 10.1016/j.msard.2018.09.039
pubmed: 30317070
Mohr DC, Classen C, Barrera M (2004) The relationship between social support, depression and treatment for depression in people with multiple sclerosis. Psychol Med 34:533–541. https://doi.org/10.1017/S0033291703001235
doi: 10.1017/S0033291703001235
pubmed: 15259838
Denis A, Callahan S, Bouvard M (2015) Evaluation of the French version of the multidimensional scale of perceived social support during the postpartum period. Matern Child Health J 19:1245–1251. https://doi.org/10.1007/s10995-014-1630-9
doi: 10.1007/s10995-014-1630-9
pubmed: 25366102
Laing CM, Cooper CL, Summers F et al (2019) The nature of anger in people with multiple sclerosis: a qualitative study. Psychol Heal. https://doi.org/10.1080/08870446.2019.1691726
doi: 10.1080/08870446.2019.1691726
Brooks SK, Webster RK, Smith LE et al (2020) The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet 395:912–920
doi: 10.1016/S0140-6736(20)30460-8
Solaro C, Trabucco E, Signori A et al (2016) Depressive symptoms correlate with disability and disease course in multiple sclerosis patients: an Italian multi-center study using the Beck Depression Inventory. PLoS ONE. https://doi.org/10.1371/journal.pone.0160261
doi: 10.1371/journal.pone.0160261
pubmed: 27632167
pmcid: 5025048